Pyxis Oncology (PYXS) Tax Rate (2024 - 2025)
Pyxis Oncology (PYXS) posted quarterly Tax Rate of 8.15% for Q4 2025, down 1389.0% year-over-year from 0.63% in Q4 2024, and down 420.52% quarter-over-quarter from 1.57% in Q2 2025.
Pyxis Oncology (PYXS) Tax Rate (2024 - 2025) Analysis & Trends
Pyxis Oncology (PYXS) has reported Tax Rate for 2 consecutive years, with 8.15% the latest figure, recorded in Q4 2025.
- In Q4 2025, Tax Rate fell 1389.0% year-over-year to 8.15%; the TTM figure through Dec 2025 stood at 0.62% (changed N/A YoY), while the FY2025 annual figure was 1.77%, down 449.0% from the prior year.
- Tax Rate fell to 8.15% in Q4 2025 per PYXS's latest filing, from 1.57% in the prior quarter.
- Across five years, Tax Rate topped out at 5.73% in Q4 2024 and bottomed at 8.15% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 20.98% |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 15.11% |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.91% |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96% |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 24.15% |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 7.49% |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 34.12% |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.71% |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Pyxis Oncology | 198.37 Mn | 165.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -8.15% |
| Dec 31, 2025 | -8.15% |
| Dec 31, 2025 | -8.15% |
| Jun 30, 2025 | -1.57% |
| Jun 30, 2025 | -1.57% |
| Jun 30, 2025 | -1.57% |
| Dec 31, 2024 | 5.73% |
| Dec 31, 2024 | 5.73% |
| Dec 31, 2024 | 5.73% |